Skip to main content

Table 2 Comparison of neuropsychological performance in controls and patients.

From: Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression

 

Control

Patient

 
 

Mean

SD

n

Mean

SD

n

p

RAVLTA1

6.85

1.48

65

5.41

1.78

71

0.0059

RAVLTA2

9.74

1.73

65

7.79

2.62

71

0.0034

RAVLTA3

11.7

1.70

65

9.06

2.74

71

0.0003

RAVLTA4

12.7

1.58

65

10.1

2.75

71

0.0003

RAVLTA5

13.6

1.29

65

10.8

2.95

71

0.0003

RAVLTATOT

54.6

6.14

65

43.1

11.6

71

0.0002

RAVLTB

6.57

1.70

65

5.00

1.87

71

0.0004

RAVLTA6

12.2

2.09

65

8.80

3.36

71

0.0027

RAVLTA7

12.1

2.57

65

8.93

3.69

71

0.0054

CPT

1.13

0.61

65

0.62

0.77

70

0.0005

TMTA

23.7

7.89

65

36.1

28.8

71

0.0251

TMTB

58.4

19.1

65

102

74.9

71

0.0007

LNS

11.0

2.26

65

8.85

3.03

71

0.0008

WAIS R

50.7

11.0

65

42.68

13.6

71

0.0131

WCST CAT

3.45

1.41

65

2.45

1.65

71

0.0798

WCST total.err

15.3

8.47

65

22.8

11.7

71

0.0246

WCST pers err

7.46

4.32

65

11.8

8.27

71

0.0719

WCST pers.resp

8.06

5.32

65

13.4

10.7

71

0.0658

  1. As a group, patients showed reduced ability in all of the tests. The difference was quite strong for all of the domains with the possible exception of the WCST. These findings are consistent with the published literature on the subject. P-values represent probability using Student's t-test (uncorrected for multiple comparisons). Applying FDR to the p-values suggests that values of p less than 0.025 are expected to have less than 5% chance of being false positives. A short description of the neuropsychological tests, including the acronyms, is given in Table 1.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us